Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity

S Matsuda1, J Kawamura-Tsuzuku, M Ohsugi

  • 1Department of Oncology, University of Tokyo, Japan.

Oncogene
|February 15, 1996
PubMed

Insights

We identified Tob, a novel protein that interacts with c-erbB-2. Tob suppresses cell growth, but this effect is reduced by active c-erbB-2, suggesting c-erbB-2 regulates Tob's anti-proliferative pathway.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Oncology

Background:

  • The c-erbB-2 proto-oncogene product p185erbB2 is a receptor-type tyrosine kinase implicated in cell growth and cancer.
  • Understanding proteins that interact with p185erbB2 is crucial for elucidating cell growth regulation.
  • The anti-proliferative gene BTG-1 shares homology with novel proteins.

Purpose of the Study:

  • To identify and characterize novel proteins interacting with the c-erbB-2 gene product p185erbB2.
  • To investigate the functional role of the novel protein Tob (Transducer of ErbB-2) in cell growth regulation.
  • To determine the interaction domains and regulatory mechanisms between Tob and p185erbB2.

Main Methods:

  • Molecular cloning and nucleotide sequencing of Tob cDNA.
  • Expression of recombinant Tob protein and analysis of its effect on NIH3T3 cell proliferation.
  • Co-immunoprecipitation assays to confirm the interaction between Tob and p185erbB2.
  • Analysis of Tob mRNA expression in various cell types.

Main Results:

  • A novel protein, Tob (Transducer of ErbB-2), was cloned and characterized. Tob is 45 kDa, homologous to BTG-1 in its N-terminal half, and interacts with p185erbB2 via its C-terminal half.
  • Exogenous Tob expression suppressed NIH3T3 cell growth, an effect diminished by kinase-active p185erbB2.
  • Co-immunoprecipitation confirmed the physical interaction between Tob and p185erbB2.
  • Tob mRNA expression was detected in various cell types and was not correlated with c-erbB-2 expression.

Conclusions:

  • p185erbB2 negatively regulates the Tob-mediated anti-proliferative pathway through direct interaction, potentially leading to growth stimulation.
  • The carboxyl-terminal half of Tob is essential for its interaction with p185erbB2.
  • Tob's regulation of cell growth may involve other receptor-type protein-tyrosine kinases besides c-erbB-2.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...